Subtopic Deep Dive

Surface Contamination by Antineoplastic Drugs
Research Guide

What is Surface Contamination by Antineoplastic Drugs?

Surface contamination by antineoplastic drugs refers to measurable residues of cytotoxic agents on work surfaces in pharmacies and hospitals, assessed via wipe sampling and analyzed for exposure risk.

Researchers quantify contamination levels of drugs like cyclophosphamide and 5-fluorouracil using wipe samples from preparation areas. Studies evaluate cleaning efficacy and map contamination hotspots across cancer treatment centers. Over 200 papers document these measurements, with key works citing 100-277 citations each.

Curated Papers

Key Challenges

Why It Matters

Surface contamination serves as the primary dermal exposure route for healthcare workers handling antineoplastic drugs, guiding decontamination protocols and protective equipment standards (Connor et al., 2006; Sessink et al., 1992). Multi-center studies across Canada, US, and Europe show widespread residues in 90% of sampled sites, informing OSHA and NIOSH guidelines (Connor et al., 1999; Sessink et al., 2010). Closed-system devices like PhaSeal reduced contamination by 80-90% in hospital pharmacies, preventing mutagenic risks to staff (Wick et al., 2003; Sessink et al., 2010).

Key Research Challenges

Quantifying Low-Level Residues

Wipe sampling detects nanogram traces of drugs like cyclophosphamide, but variability in extraction efficiency and analytical sensitivity limits reproducibility (Connor et al., 1999). LC-MS/MS methods improve detection but require standardized protocols across labs (Sessink et al., 1992).

Evaluating Cleaning Efficacy

Surface decontamination protocols vary, with sodium hypochlorite reducing residues inconsistently across surfaces (Hedmer et al., 2007). Studies show post-cleaning residues persist in 50% of sites, challenging validation of hospital practices (Wick et al., 2003).

Mapping Contamination Spread

Contamination migrates from preparation hoods to floors and doorknobs, complicating exposure modeling (Connor et al., 1999). Multi-site surveys reveal pharmacy bins and IV poles as hotspots, but airflow and traffic patterns remain understudied (Sessink et al., 2010).

Essential Papers

Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings

Thomas H. Connor, Melissa A. McDiarmid · 2006 · CA A Cancer Journal for Clinicians · 277 citations

The toxicity of antineoplastic drugs has been well known since they were introduced in the 1940s. Because most antineoplastic drugs are nonselective in their mechanism of action, they affect noncan...

Occupational exposure to antineoplastic agents at several departments in a hospital

P.J.M. Sessink, K. A. Boer, A. P. H. Scheefhals et al. · 1992 · International Archives of Occupational and Environmental Health · 271 citations

Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States

Thomas H. Connor, Roger W. Anderson, P.J.M. Sessink et al. · 1999 · American Journal of Health-System Pharmacy · 216 citations

The level of contamination by antineoplastic agents in drug preparation and administration areas in cancer treatment centers in Canada and the United States was determined. Sampling locations at th...

Using a closed-system protective device to reduce personnel exposure to antineoplastic agents

Catherine Wick, Matthew H. Slawson, James A. Jorgenson et al. · 2003 · American Journal of Health-System Pharmacy · 159 citations

Surface contamination with and personnel exposure to antineoplastic agents before and after the implementation of a closed-system protective device were studied. Samples were collected before and s...

Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device

P.J.M. Sessink, Thomas H. Connor, James A. Jorgenson et al. · 2010 · Journal of Oncology Pharmacy Practice · 153 citations

Purpose. Surface contamination with the antineoplastic drugs cyclophosphamide, ifosfamide, and 5-fluorouracil was compared in 22 US hospital pharmacies following preparation with standard drug prep...

American College of Chest Physicians and American Association for Bronchology Consensus Statement

Atul C. Mehta, Udaya B. S. Prakash, Robert Garland et al. · 2005 · CHEST Journal · 143 citations

Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital

Maria Hedmer, Håkan Tinnerberg, Anna Axmon et al. · 2007 · International Archives of Occupational and Environmental Health · 124 citations

Reading Guide

Foundational Papers

Start with Connor et al. (2006; 277 citations) for exposure overview, then Sessink et al. (1992; 271 citations) for early quantification, and Connor et al. (1999; 216 citations) for multi-center wipe data baselines.

Recent Advances

Study Sessink et al. (2010; 153 citations) for PhaSeal impacts in 22 pharmacies and Hedmer et al. (2007; 124 citations) for Swedish biological monitoring.

Core Methods

Wipe sampling with cotton swabs, methanol extraction, LC-MS/MS analysis for ng-μg/m² detection; closed-system testing via pre/post-intervention comparisons (Wick et al., 2003).

How PapersFlow Helps You Research Surface Contamination by Antineoplastic Drugs

Discover & Search

PapersFlow's Research Agent uses searchPapers and citationGraph to trace contamination studies from Connor et al. (1999; 216 citations) to Sessink et al. (2010), mapping 50+ related works on wipe sampling. exaSearch uncovers hospital-specific protocols, while findSimilarPapers expands from Sessink et al. (1992) to European sites.

Analyze & Verify

Analysis Agent employs readPaperContent on Connor et al. (2006) to extract wipe sample data, then runPythonAnalysis with pandas to compute mean residue levels across 22 pharmacies from Sessink et al. (2010). verifyResponse via CoVe cross-checks claims against raw μg/m² measurements, with GRADE grading assigning high evidence to PhaSeal reductions (Wick et al., 2003).

Synthesize & Write

Synthesis Agent detects gaps in post-2010 closed-system data via contradiction flagging between Sessink et al. (2010) and earlier works. Writing Agent uses latexEditText and latexSyncCitations to draft protocols citing Connor et al. (1999), with latexCompile generating hospital-ready PDFs and exportMermaid visualizing contamination flowcharts.

Use Cases

"Analyze wipe sample data from US hospital pharmacies for cyclophosphamide residues."

Research Agent → searchPapers('cyclophosphamide surface contamination Sessink') → Analysis Agent → readPaperContent(Sessink 2010) → runPythonAnalysis(pandas mean/SEM on μg/m² data) → researcher gets CSV of pre/post-PhaSeal stats with p-values.

"Draft LaTeX report on PhaSeal efficacy in reducing antineoplastic contamination."

Synthesis Agent → gap detection(Sessink 2010 + Wick 2003) → Writing Agent → latexEditText('decontamination protocol') → latexSyncCitations(Connor 1999) → latexCompile → researcher gets compiled PDF with figures and bibliography.

"Find code for modeling antineoplastic drug surface migration."

Research Agent → citationGraph(Connor 1999) → Code Discovery → paperExtractUrls → paperFindGithubRepo('wipe sampling simulation') → githubRepoInspect → researcher gets Python scripts for residue diffusion models.

Automated Workflows

Deep Research workflow conducts systematic reviews of 50+ papers, chaining searchPapers on 'antineoplastic wipe samples' to structured reports ranking Connor et al. (1999) highest by citations. DeepScan applies 7-step analysis with CoVe checkpoints to verify Sessink et al. (2010) data against Hedmer et al. (2007). Theorizer generates exposure models from contamination patterns in Wick et al. (2003).

Try Doxa for Surface Contamination by Antineoplastic Drugs Research

Frequently Asked Questions

What is surface contamination by antineoplastic drugs?

It measures cytotoxic drug residues like cyclophosphamide on pharmacy and hospital surfaces via wipe sampling (Connor et al., 1999).

What methods detect surface contamination?

Wipe samples extracted with methanol and analyzed by LC-MS/MS quantify μg/m² levels of 5-fluorouracil and ifosfamide (Sessink et al., 2010).

What are key papers on this topic?

Connor et al. (1999; 216 citations) surveyed six centers; Sessink et al. (1992; 271 citations) first quantified hospital exposures; Wick et al. (2003; 159 citations) tested PhaSeal.